Retinal changes: a mortality risk in non-diabetics

Article

A study published in the September issue of the American Journal of Epidemiology, suggests that retinal changes have possible prognostic implications regarding the survival of persons with diabetes.

A study published in the September issue of the American Journal of Epidemiology, suggests that retinal changes have possible prognostic implications regarding the survival of persons with diabetes.

Despite retinopathy being fairly common among non-diabetics, its prognostic implications are not fully understood. Ronald Klein and colleagues from the University of Wisconsin, USA and the Federal University of Sao Paulo, Brazil hypothesized that retinal alterations are associated with increased mortality. In order to investigate this, they evaluated survival rates among 4,292 non-diabetic participants (age range, 43-84 years) of the Beaver Dam Eye Study.

Retinal photographs were used to classify retinopathy into four groups: no retinopathy, retinal haemorrhage only, retinal micro-aneurysm or moderate or worse retinopathy. Survival was analyzed over a 14-year follow-up period in five-year intervals.

The baseline prevalence of retinopathy was 7.6%. After the 14-year follow-up period it was discovered that moderate retinopathy, at baseline, increased the risk of all-cause mortality by 24% and ischaemic heart disease by more than three-fold.

Based on these results, the researchers believe that retinal changes do have possible prognostic implications regarding the survival of persons without diabetes.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.